In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Breathe Technologies brings in $23mm through its Series C round

27 May 2010

Executive Summary

Respiratory device company Breathe Technologies Inc. has raised $23mm through the closing of its Series C venture round. DAG Ventures led and was joined by fellow new investor Johnson & Johnson Development Corp. (both will contribute one board member) and current shareholders Kleiner Perkins Caufield & Byers, Delphi Ventures, and Synergy Partners International.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Rehabilitation Equipment and Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By